Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Thereson Nov 23, 2009 9:42am
327 Views
Post# 16513574

RE: Better than expected financials out now !

RE: Better than expected financials out now !

What that's mean for today SP? Up or down way?

SCT will be issuing an aggregate of 3,695,000 stock options to the Company's officers, Board of Directors, employees and Advisory Board members on November 24, 2009. The exercise price of the Options will be the closing price of November 23, 2009. These options will expire no later than November 24, 2014 subject to applicable vesting provisions

Thank for explain

Theres

Bullboard Posts